Structure

Physi-Chem Properties

Molecular Weight:  626.15
Volume:  561.108
LogP:  -0.66
LogD:  -0.415
LogS:  -2.999
# Rotatable Bonds:  7
TPSA:  289.66
# H-Bond Aceptor:  17
# H-Bond Donor:  11
# Rings:  5
# Heavy Atoms:  17

MedChem Properties

QED Drug-Likeness Score:  0.119
Synthetic Accessibility Score:  4.785
Fsp3:  0.444
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.532
MDCK Permeability:  1.9244580471422523e-05
Pgp-inhibitor:  0.011
Pgp-substrate:  0.971
Human Intestinal Absorption (HIA):  0.921
20% Bioavailability (F20%):  0.058
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.076
Plasma Protein Binding (PPB):  84.37129211425781%
Volume Distribution (VD):  0.687
Pgp-substrate:  18.52317237854004%

ADMET: Metabolism

CYP1A2-inhibitor:  0.083
CYP1A2-substrate:  0.016
CYP2C19-inhibitor:  0.014
CYP2C19-substrate:  0.044
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.077
CYP2D6-inhibitor:  0.017
CYP2D6-substrate:  0.132
CYP3A4-inhibitor:  0.029
CYP3A4-substrate:  0.003

ADMET: Excretion

Clearance (CL):  1.345
Half-life (T1/2):  0.835

ADMET: Toxicity

hERG Blockers:  0.422
Human Hepatotoxicity (H-HT):  0.13
Drug-inuced Liver Injury (DILI):  0.982
AMES Toxicity:  0.812
Rat Oral Acute Toxicity:  0.017
Maximum Recommended Daily Dose:  0.001
Skin Sensitization:  0.861
Carcinogencity:  0.036
Eye Corrosion:  0.003
Eye Irritation:  0.144
Respiratory Toxicity:  0.011

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC254855

Natural Product ID:  NPC254855
Common Name*:   Quercetin 3-O-(2-O-Beta-D-Glucopyranosyl)-Beta-D-Galactopyranoside
IUPAC Name:   3-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
Synonyms:  
Standard InCHIKey:  RDUAJIJVNHKTQC-PABQPRPFSA-N
Standard InCHI:  InChI=1S/C27H30O17/c28-6-14-17(34)20(37)22(39)26(41-14)44-25-21(38)18(35)15(7-29)42-27(25)43-24-19(36)16-12(33)4-9(30)5-13(16)40-23(24)8-1-2-10(31)11(32)3-8/h1-5,14-15,17-18,20-22,25-35,37-39H,6-7H2/t14-,15-,17-,18+,20+,21+,22-,25-,26+,27+/m1/s1
SMILES:  c1cc(c(cc1c1c(c(=O)c2c(cc(cc2o1)O)O)O[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL452919
PubChem CID:   14185728
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003531] Flavonoid-3-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32921 hedyotis diffusa Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[11170670]
NPO32921 hedyotis diffusa Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[20004577]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified Activity = 48.2 % PMID[550068]
NPT2 Others Unspecified Activity = 66.0 % PMID[550068]
NPT2 Others Unspecified Activity = 54.0 % PMID[550068]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC254855 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC259896
1.0 High Similarity NPC136042
1.0 High Similarity NPC29958
1.0 High Similarity NPC67326
1.0 High Similarity NPC156869
1.0 High Similarity NPC255157
0.9938 High Similarity NPC176740
0.9938 High Similarity NPC471725
0.9938 High Similarity NPC33054
0.9938 High Similarity NPC155877
0.9938 High Similarity NPC134532
0.9938 High Similarity NPC26230
0.9938 High Similarity NPC471748
0.9938 High Similarity NPC60735
0.9938 High Similarity NPC203259
0.9875 High Similarity NPC67105
0.9875 High Similarity NPC285197
0.9875 High Similarity NPC95866
0.9874 High Similarity NPC275454
0.9815 High Similarity NPC473327
0.9815 High Similarity NPC16194
0.9815 High Similarity NPC476472
0.9815 High Similarity NPC253685
0.9815 High Similarity NPC220173
0.9815 High Similarity NPC294815
0.9815 High Similarity NPC19108
0.9812 High Similarity NPC227508
0.9811 High Similarity NPC88789
0.9811 High Similarity NPC145038
0.9811 High Similarity NPC56077
0.9811 High Similarity NPC179950
0.9811 High Similarity NPC253662
0.9811 High Similarity NPC8856
0.9811 High Similarity NPC276222
0.9811 High Similarity NPC118284
0.9811 High Similarity NPC274618
0.9811 High Similarity NPC308404
0.9811 High Similarity NPC281131
0.9755 High Similarity NPC122467
0.9755 High Similarity NPC219043
0.9755 High Similarity NPC470949
0.9755 High Similarity NPC14187
0.9755 High Similarity NPC202908
0.9755 High Similarity NPC292019
0.9755 High Similarity NPC471669
0.9755 High Similarity NPC89127
0.9755 High Similarity NPC8573
0.9755 High Similarity NPC65563
0.975 High Similarity NPC92565
0.975 High Similarity NPC173637
0.975 High Similarity NPC160156
0.975 High Similarity NPC52550
0.975 High Similarity NPC317489
0.975 High Similarity NPC84362
0.975 High Similarity NPC127546
0.975 High Similarity NPC223424
0.9748 High Similarity NPC277205
0.9748 High Similarity NPC240431
0.9748 High Similarity NPC19388
0.9748 High Similarity NPC55786
0.9695 High Similarity NPC89052
0.9695 High Similarity NPC173837
0.9695 High Similarity NPC251417
0.9693 High Similarity NPC294629
0.9689 High Similarity NPC86008
0.9689 High Similarity NPC52382
0.9689 High Similarity NPC225434
0.9689 High Similarity NPC120099
0.9689 High Similarity NPC270578
0.9689 High Similarity NPC203050
0.9689 High Similarity NPC219904
0.9689 High Similarity NPC223747
0.9688 High Similarity NPC21100
0.9688 High Similarity NPC197285
0.9688 High Similarity NPC210073
0.9688 High Similarity NPC113968
0.9688 High Similarity NPC115674
0.9688 High Similarity NPC135599
0.9688 High Similarity NPC277174
0.9688 High Similarity NPC73855
0.9688 High Similarity NPC328940
0.9636 High Similarity NPC241423
0.9636 High Similarity NPC192539
0.9636 High Similarity NPC473682
0.9636 High Similarity NPC470444
0.9636 High Similarity NPC473571
0.9636 High Similarity NPC110941
0.9636 High Similarity NPC470443
0.9636 High Similarity NPC126784
0.9634 High Similarity NPC473862
0.9634 High Similarity NPC169733
0.9634 High Similarity NPC48984
0.963 High Similarity NPC244776
0.963 High Similarity NPC218488
0.963 High Similarity NPC206123
0.963 High Similarity NPC235260
0.963 High Similarity NPC20505
0.963 High Similarity NPC155763
0.963 High Similarity NPC116864
0.9627 High Similarity NPC265530
0.9627 High Similarity NPC226304
0.9627 High Similarity NPC325555
0.9623 High Similarity NPC77660
0.9623 High Similarity NPC189142
0.9578 High Similarity NPC473073
0.9578 High Similarity NPC473071
0.9576 High Similarity NPC37668
0.9576 High Similarity NPC113836
0.9576 High Similarity NPC253521
0.9573 High Similarity NPC81042
0.9573 High Similarity NPC223426
0.9573 High Similarity NPC214621
0.9573 High Similarity NPC34267
0.9571 High Similarity NPC180918
0.9571 High Similarity NPC3583
0.9571 High Similarity NPC190003
0.9571 High Similarity NPC175107
0.9571 High Similarity NPC245452
0.9571 High Similarity NPC259152
0.9571 High Similarity NPC153755
0.9568 High Similarity NPC209296
0.9568 High Similarity NPC138927
0.9568 High Similarity NPC105283
0.9568 High Similarity NPC195257
0.9565 High Similarity NPC255615
0.9565 High Similarity NPC67037
0.9563 High Similarity NPC270335
0.9563 High Similarity NPC168822
0.9563 High Similarity NPC29830
0.9563 High Similarity NPC19709
0.9563 High Similarity NPC191306
0.956 High Similarity NPC64305
0.956 High Similarity NPC135846
0.956 High Similarity NPC297987
0.956 High Similarity NPC170052
0.9521 High Similarity NPC470718
0.9521 High Similarity NPC470446
0.9521 High Similarity NPC162394
0.9521 High Similarity NPC470447
0.9521 High Similarity NPC156785
0.9521 High Similarity NPC241781
0.9521 High Similarity NPC473072
0.9521 High Similarity NPC470445
0.9521 High Similarity NPC470449
0.9515 High Similarity NPC144097
0.9515 High Similarity NPC61904
0.9512 High Similarity NPC42773
0.9512 High Similarity NPC101026
0.9512 High Similarity NPC4390
0.9512 High Similarity NPC21666
0.9512 High Similarity NPC45522
0.9512 High Similarity NPC24043
0.9512 High Similarity NPC169977
0.9509 High Similarity NPC245014
0.9509 High Similarity NPC84265
0.9509 High Similarity NPC150767
0.9509 High Similarity NPC231194
0.9509 High Similarity NPC78734
0.9509 High Similarity NPC282987
0.9509 High Similarity NPC51326
0.9506 High Similarity NPC149244
0.9506 High Similarity NPC48640
0.9503 High Similarity NPC22832
0.9503 High Similarity NPC311830
0.9503 High Similarity NPC34531
0.95 High Similarity NPC473043
0.9497 High Similarity NPC136761
0.9497 High Similarity NPC470405
0.9497 High Similarity NPC304741
0.9497 High Similarity NPC471079
0.9464 High Similarity NPC249560
0.9464 High Similarity NPC470717
0.9464 High Similarity NPC148710
0.9464 High Similarity NPC25946
0.9464 High Similarity NPC460984
0.9464 High Similarity NPC470720
0.9464 High Similarity NPC470451
0.9464 High Similarity NPC275977
0.9464 High Similarity NPC223860
0.9464 High Similarity NPC21359
0.9464 High Similarity NPC470455
0.9464 High Similarity NPC470713
0.9458 High Similarity NPC258044
0.9458 High Similarity NPC139571
0.9458 High Similarity NPC217520
0.9458 High Similarity NPC35167
0.9458 High Similarity NPC267680
0.9458 High Similarity NPC293626
0.9458 High Similarity NPC217387
0.9458 High Similarity NPC196127
0.9455 High Similarity NPC135277
0.9455 High Similarity NPC49344
0.9455 High Similarity NPC101191
0.9455 High Similarity NPC210094
0.9455 High Similarity NPC115760
0.9455 High Similarity NPC43211
0.9455 High Similarity NPC198199
0.9455 High Similarity NPC237435
0.9451 High Similarity NPC476405
0.9451 High Similarity NPC117260

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC254855 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9938 High Similarity NPD6797 Phase 2
0.9876 High Similarity NPD7251 Discontinued
0.9693 High Similarity NPD7808 Phase 3
0.963 High Similarity NPD7472 Approved
0.9568 High Similarity NPD7054 Approved
0.9455 High Similarity NPD4338 Clinical (unspecified phase)
0.939 High Similarity NPD7074 Phase 3
0.9212 High Similarity NPD7804 Clinical (unspecified phase)
0.9152 High Similarity NPD3818 Discontinued
0.9146 High Similarity NPD6168 Clinical (unspecified phase)
0.9146 High Similarity NPD6166 Phase 2
0.9146 High Similarity NPD6167 Clinical (unspecified phase)
0.913 High Similarity NPD4381 Clinical (unspecified phase)
0.8773 High Similarity NPD3817 Phase 2
0.8765 High Similarity NPD1934 Approved
0.8742 High Similarity NPD1512 Approved
0.8712 High Similarity NPD2393 Clinical (unspecified phase)
0.8655 High Similarity NPD7993 Clinical (unspecified phase)
0.8616 High Similarity NPD1511 Approved
0.8606 High Similarity NPD3882 Suspended
0.8598 High Similarity NPD2801 Approved
0.8528 High Similarity NPD4380 Phase 2
0.8494 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD7075 Discontinued
0.8434 Intermediate Similarity NPD5402 Approved
0.8344 Intermediate Similarity NPD5403 Approved
0.8313 Intermediate Similarity NPD6801 Discontinued
0.8286 Intermediate Similarity NPD6559 Discontinued
0.8263 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD5401 Approved
0.8161 Intermediate Similarity NPD3751 Discontinued
0.816 Intermediate Similarity NPD6799 Approved
0.814 Intermediate Similarity NPD3787 Discontinued
0.8125 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8077 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD1549 Phase 2
0.8072 Intermediate Similarity NPD1653 Approved
0.8023 Intermediate Similarity NPD5494 Approved
0.7989 Intermediate Similarity NPD8313 Approved
0.7989 Intermediate Similarity NPD8312 Approved
0.7977 Intermediate Similarity NPD6959 Discontinued
0.7941 Intermediate Similarity NPD1465 Phase 2
0.7895 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD1510 Phase 2
0.787 Intermediate Similarity NPD6599 Discontinued
0.7853 Intermediate Similarity NPD7228 Approved
0.784 Intermediate Similarity NPD2796 Approved
0.7836 Intermediate Similarity NPD7819 Suspended
0.7824 Intermediate Similarity NPD7411 Suspended
0.7809 Intermediate Similarity NPD5844 Phase 1
0.7784 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7685 Pre-registration
0.775 Intermediate Similarity NPD1613 Approved
0.775 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD8455 Phase 2
0.7727 Intermediate Similarity NPD6232 Discontinued
0.7711 Intermediate Similarity NPD6190 Approved
0.7697 Intermediate Similarity NPD7473 Discontinued
0.7692 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD6776 Approved
0.7684 Intermediate Similarity NPD6782 Approved
0.7684 Intermediate Similarity NPD6781 Approved
0.7684 Intermediate Similarity NPD6778 Approved
0.7684 Intermediate Similarity NPD6777 Approved
0.7684 Intermediate Similarity NPD6779 Approved
0.7684 Intermediate Similarity NPD6780 Approved
0.7683 Intermediate Similarity NPD7266 Discontinued
0.767 Intermediate Similarity NPD7199 Phase 2
0.7657 Intermediate Similarity NPD919 Approved
0.7656 Intermediate Similarity NPD7435 Discontinued
0.7641 Intermediate Similarity NPD8151 Discontinued
0.764 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7581 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD1247 Approved
0.7565 Intermediate Similarity NPD7698 Approved
0.7565 Intermediate Similarity NPD7697 Approved
0.7565 Intermediate Similarity NPD7696 Phase 3
0.7557 Intermediate Similarity NPD6234 Discontinued
0.7545 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD3750 Approved
0.7538 Intermediate Similarity NPD7584 Approved
0.7531 Intermediate Similarity NPD1240 Approved
0.7531 Intermediate Similarity NPD943 Approved
0.753 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7701 Phase 2
0.7486 Intermediate Similarity NPD7240 Approved
0.7486 Intermediate Similarity NPD3926 Phase 2
0.7471 Intermediate Similarity NPD37 Approved
0.7443 Intermediate Similarity NPD4966 Approved
0.7443 Intermediate Similarity NPD4965 Approved
0.7443 Intermediate Similarity NPD4967 Phase 2
0.7439 Intermediate Similarity NPD1607 Approved
0.7438 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD7870 Phase 2
0.7436 Intermediate Similarity NPD7871 Phase 2
0.7435 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7424 Intermediate Similarity NPD7874 Approved
0.7424 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD6535 Approved
0.7421 Intermediate Similarity NPD6534 Approved
0.7412 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1551 Phase 2
0.7401 Intermediate Similarity NPD3749 Approved
0.7396 Intermediate Similarity NPD7700 Phase 2
0.7396 Intermediate Similarity NPD7699 Phase 2
0.7387 Intermediate Similarity NPD7783 Phase 2
0.7387 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD1933 Approved
0.7378 Intermediate Similarity NPD230 Phase 1
0.7349 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD8319 Approved
0.7347 Intermediate Similarity NPD8320 Phase 1
0.7346 Intermediate Similarity NPD3027 Phase 3
0.7345 Intermediate Similarity NPD7768 Phase 2
0.7337 Intermediate Similarity NPD4628 Phase 3
0.7301 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD7801 Approved
0.7246 Intermediate Similarity NPD3748 Approved
0.7245 Intermediate Similarity NPD6823 Phase 2
0.7202 Intermediate Similarity NPD2935 Discontinued
0.7196 Intermediate Similarity NPD8434 Phase 2
0.7196 Intermediate Similarity NPD8150 Discontinued
0.7176 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD1091 Approved
0.7169 Intermediate Similarity NPD447 Suspended
0.7168 Intermediate Similarity NPD2532 Approved
0.7168 Intermediate Similarity NPD2534 Approved
0.7168 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD2533 Approved
0.7158 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7585 Approved
0.7102 Intermediate Similarity NPD7458 Discontinued
0.71 Intermediate Similarity NPD7583 Approved
0.7092 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD6798 Discontinued
0.7086 Intermediate Similarity NPD920 Approved
0.7081 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD2800 Approved
0.7074 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD4363 Phase 3
0.7062 Intermediate Similarity NPD4360 Phase 2
0.7059 Intermediate Similarity NPD5953 Discontinued
0.7056 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD6233 Phase 2
0.7041 Intermediate Similarity NPD7033 Discontinued
0.7035 Intermediate Similarity NPD7680 Approved
0.7011 Intermediate Similarity NPD7390 Discontinued
0.701 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD6213 Phase 3
0.701 Intermediate Similarity NPD6212 Phase 3
0.7006 Intermediate Similarity NPD3226 Approved
0.7 Intermediate Similarity NPD6099 Approved
0.7 Intermediate Similarity NPD6100 Approved
0.6994 Remote Similarity NPD1203 Approved
0.6988 Remote Similarity NPD2313 Discontinued
0.6983 Remote Similarity NPD6844 Discontinued
0.6977 Remote Similarity NPD1243 Approved
0.6977 Remote Similarity NPD6674 Discontinued
0.6977 Remote Similarity NPD1652 Phase 2
0.697 Remote Similarity NPD4908 Phase 1
0.697 Remote Similarity NPD6832 Phase 2
0.6964 Remote Similarity NPD6355 Discontinued
0.6957 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6952 Remote Similarity NPD7286 Phase 2
0.6951 Remote Similarity NPD2798 Approved
0.6923 Remote Similarity NPD6651 Approved
0.6918 Remote Similarity NPD1548 Phase 1
0.691 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6909 Remote Similarity NPD9494 Approved
0.6886 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6881 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6864 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5124 Phase 1
0.686 Remote Similarity NPD2346 Discontinued
0.686 Remote Similarity NPD2344 Approved
0.6852 Remote Similarity NPD1610 Phase 2
0.6842 Remote Similarity NPD2799 Discontinued
0.6839 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6829 Remote Similarity NPD3225 Approved
0.6813 Remote Similarity NPD5353 Approved
0.681 Remote Similarity NPD9269 Phase 2
0.6809 Remote Similarity NPD2163 Approved
0.6805 Remote Similarity NPD4060 Phase 1
0.6791 Remote Similarity NPD2403 Approved
0.6786 Remote Similarity NPD3268 Approved
0.678 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6779 Remote Similarity NPD7930 Approved
0.6774 Remote Similarity NPD5710 Approved
0.6774 Remote Similarity NPD5711 Approved
0.6765 Remote Similarity NPD4340 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data